Clinical trial
Evaluation of Postoperative Pain, Pain Catastrophizing, Dental Anxiety, and Salivary Irisin Levels in Patients With and Without Intracanal Cryotherapy Application During Single-Visit Root Canal Treatment
NCT07889050 is registered in ClinicalTrials.gov with Alanya Alaaddin Keykubat University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Postoperative Pain, Pain Catastrophizing, Dental Anxiety, and Salivary Irisin Levels in Patients With and Without Intracanal Cryotherapy Application During Single-Visit Root Canal Treatment
- Lead sponsor
- Alanya Alaaddin Keykubat University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- February 15, 2028
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dental anxiety, postoperative pain after endodontic treatment, root canal treatment
Arms
As registered; 3 arms.
-
Intracanal cryotherapy
Participants undergoing single-visit root canal treatment will receive intracanal cryotherapy using a cold irrigant delivered through a closed-system irrigation device (EndoVac) after completion of canal instrumentation and prior to obturation.
-
Room-temperature irrigation (control)
Participants undergoing single-visit root canal treatment will receive standard irrigation using the same closed-system irrigation device (EndoVac) with irrigant at room temperature, following the same canal instrumentation protocol as the intervention group.
-
Healthy reference group
Saliva samples will be collected from healthy participants without an indication for root canal treatment, solely for the purpose of establishing normative salivary irisin reference values. These participants will not be randomized, will not undergo root canal treatment, and will not receive any study intervention.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Postoperative pain assessed by Visual Analog Scale (VAS)
Postoperative pain will be self-assessed by participants using a 100 mm Visual Analog Scale (VAS), consisting of a horizontal line where participants mark the point that best represents their level of pain intensity. The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Scores are measured in millimeters, with higher scores indicating greater pain intensity. Participants will record their VAS score in a standardized pain diary at each assessment time point, along with any rescue analgesic (paracetamol 500 mg) use, including time and dose, and any adverse events or unexpected occurrences. A blinded researcher, unaware of group allocation, will telephone participants at each designated time point to record pain scores and remind them to complete the diary.
Lead sponsor's other trials
Alanya Alaaddin Keykubat University, most recent start first.
+45 more trials
Similar trials
Same condition (Postoperative Pain) and phase, most recent start first.
+2,870 more trials See the condition page